Consumer Products

Marijuana News Roundup: Not All California Pot Growers Favor Proposition 64

Paul Ausick

No Decision on Rescheduling Marijuana Prompts Congressional Action
The DEA’s [Drug Enforcement Agency] evaluation of marijuana and its place in the Schedule of Controlled Substances Act generated media coverage in 2016, but fizzled out when the organization’s self-proclaimed deadline came and went without a decision at all. What appeared to be a chance at moving cannabis from Schedule 1, reserved for the most dangerous drugs with no medicinal value, to a more appropriate Schedule listing vanished without a word.

One group of legislators is calling on DEA leaders to make a decision.

On April 4, 2016, the DEA sent a letter to members of Congress who had asked them to consider rescheduling cannabis from Schedule 1. In it the authors claimed they would have an answer on the issue of rescheduling in the first half of 2016. They missed their deadline, but pundits are still calling for a decision any day now. On July 11, the Denver Post reported that a top DEA official said they weren’t going to hold themselves to any “artificial time frame,” even if it is a timeline they gave themselves.

Sen. Kirsten Gillibrand is one of eight Congresspersons who challenged DEA Administrator Rosenberg to address the issue  via a letter sent on June 30 to his office.

In the letter and the accompanying press release, the group cites the reasons for removing marijuana from Schedule 1, saying, “information from the Department of Health and Human Services (HHS)… has already determined that medication naturally derived from the cannabis plant has a medical use.”

Read more at The Weed Blog.

Marijuana Dollars Are Having a Huge Impact on the Civic Soul of Edgewater
This may not be the city that cannabis built, but Colorado’s most famous cash crop could soon be the driving force behind construction of a $7 million, 40,000-square-foot civic center in this tiny community wedged between Lakewood and Denver.

Edgewater is exploring using sales tax revenue from marijuana sales to cover more than half the cost — $4 million — of building a facility that will house a new city hall, police station, fitness center and library.

It’s a project that likely wouldn’t move forward — at least not for years — absent the tax remittances made by the city’s half-dozen pot shops. The city expects to collect north of $1.2 million in sales tax revenues from pot in 2016.

“There is no way we could have gotten the civic center together as quickly as we have without the retail marijuana revenue,” Edgewater Mayor Kristian Teegardin said Thursday. “Having that retail sales tax from marijuana definitely sped up the process.”

Read more at The Denver Post.

Medical Marijuana Industry Spreading Its Roots in Region
The rollout of the 2013 state law legalizing the sale of medical marijuana has proceeded at a snail’s pace in Massachusetts, with just six dispensaries in operation.

But under a revamped state licensure process, the fledgling industry is gaining traction, and the south suburbs [of Boston] are seeing their share of the increased activity.

One business is selling its product in Brockton, another expects to open its doors in Quincy this fall, and more than a dozen others are scouting locations, building facilities, and seeking regulatory approvals in municipalities from Bridgewater to Wareham.

In Brockton, In Good Health was the second dispensary to open in the state when it began sales last September. Today, the 25-employee business serves more than 1,000 patients weekly from its West Chestnut Street location, where it also cultivates the plant.

Read more at The Boston Globe.